The AfterRaise week
70 rounds, $6.4B of announced capital. The largest: Imprint raised $2.0B. Sorted by size; every figure links to its source.
The company said the funding supports diversify its funding sources, reduce the cost of fund margin, and support the continued growth and scaling of its programs.
The company said the funding supports fund the acquisition and installation of GPU servers and related infrastructure used to deliver compute services dedicated to an investment-grade offtaker, and support the expansion of its platform.
The company said the funding supports build out manufacturing capacity, support engineering work in collaboration with NVIDIA, and secure procurement of future launch allocation.
The company said the funding supports scale manufacturing, execute key certification milestones, expand engineering, advance commercial and defense pipelines, and deliver Seagliders to customers.
The company said the funding supports expand its high-frequency regional route network and scale its fleet from dozens to thousands of driverless trucks.
The announcement did not set out what the funding supports.
The company said the funding supports finance Project Obsidian, and accelerate the commercialization of its millimeter wave drilling system toward depths in excess of 5 km.
The company said the funding supports global expansion and integration of Fravity's 1st party agent building capabilities natively into its RiskOS platform.
The company said the funding supports expand operations and its development efforts Led by Founder and CEO Dr.
The company said the funding supports support construction, equipment, and operational readiness activities at its magnet manufacturing plant in Sartell, Minnesota.
The company said the funding supports further advance its AI platform, deepening the technology that tests, defends, and monitors AI models across their lifecycle, expand the team behind its proprietary dataset (Rabbit Hole), and scale its go-to-market organization serving foundation model labs and enterprises.
The company said the funding supports support the continued development of AHB-137, including its Phase 3 registrational program and commercialization readiness, accelerate the development of AHB-171, advance new combination approaches for CHB, and expand its pipeline of targeted oligonucleotide therapeutics.
The announcement did not set out what the funding supports.
The announcement did not set out what the funding supports.
The company said the funding supports fuel its next stage of growth, expand its impact across the women's basketball ecosystem, support its players, and elevate the fan experience.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports fuel the development of its product suite for creative production, deepen its applied research discipline, and expand its professional services arm.
The company said the funding supports accelerate the deployment of its rare earth recycling campus in South Carolina and expand its Hub-and-Spoke infrastructure across the United States.
The announcement did not set out what the funding supports.
The company said the funding supports support its expansion across North America, Asia, and the Middle East, accelerate investment in its technology and product capabilities (including digital assets and tokenization), and expand its capacity to serve financial institutions accessing U.S.
The announcement did not set out what the funding supports.
The company said the funding supports expand its research and engineering team, scale the infrastructure required to train frontier models, advance future Cogito releases, and grow its work with enterprises building specialized intelligence on proprietary data.
The company said the funding supports further maturation of its comb laser, including sampling, reliability/qualification, ramping up manufacturing, and developing other optical components such as semiconductor optical amplifiers and optical engines.
The company said the funding supports expand its agentic AI capabilities and accelerate its work with customers deploying AI agents across their development organizations.
The company said the funding supports advance its core technologies and infrastructure, dedicate research capabilities to establishing a foothold in the domestic and international enterprise AX markets, acquire global talent, as well as conduct marketing, and business expansion activities.
The company said the funding supports advance its ProFoundry platform and agentic AI capabilities to discover novel biomarkers, protein drugs, and drug targets for preeclampsia and eclampsia Led by CEO John Lepore, ProFound Therapeutics is a biotechnology company focused on uncovering new protein drugs and drug targets hidden within the expanded human proteome.
The announcement did not set out what the funding supports.
The company said the funding supports accelerate the development of new fraud prevention defenses and monitoring technology, including motor vehicle reports, OIG exclusion monitoring, and automated alerts for expiring worker licenses, insurance, or certifications.
The company said the funding supports expand its product development team in Portugal, enhance design and AI leadership in California to broaden power management applications, and accelerate its design automation roadmap.
The company said the funding supports launch and expand its operations in the U.S.
The company said the funding supports grow the team, bring more ranchers and farmers onto the platform, and enhance the platform to capture more data points such as genomic data.
The company said the funding supports accelerate its national expansion and deepen its product capabilities.
The company said the funding supports scale its platform and expand its AI/machine learning and agentic capabilities.
The company said the funding supports grow its engineering team based across the Bay Area and Europe, expand its independent web index and crawling infrastructure, and continue developing the retrieval systems underpinning Web Query Language.
The announcement did not set out what the funding supports.
The announcement did not set out what the funding supports.
The company said the funding supports expand across more enterprise health systems, deepen its clinical and specialty coverage, and extend the platform to new areas of the revenue cycle.
The company said the funding supports hire researchers and engineers, build out agent-native tooling, and expand enterprise customer engagements across chip verification and physical design.
The announcement did not set out what the funding supports.
The company said the funding supports expand hiring across engineering and sales roles in San Francisco and manufacturing in Peoria, and extend the platform beyond insoles to serve the broader durable medical equipment (DME) market.
The Daily Brief
Every disclosed US, UK and European round of $5M or more, with what each company said the money supports, the morning it is observed. One email, only on days something happened, unsubscribe with one click.